• Join
  • Login
  • Contact

Search abstracts

Immunogenicity of biosimilars: considerations related to evaluation strategy and challenges

  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: AMARAVADI, Lakshmi (BiogenIdec, Translational Medicine, Cambridge, ma, United States of America)
  • Abstract:

    As the Biosimilar landscape is rapidly evolving there is also a parallel evolution of newer technologies that allow for development improved immunogenicity assays. In addition there are a variety of scenarios that may be applicable for biosimilar immunogenicity evaluation where a biosimilar is being compared with the original therapeutic. In this..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses